论文部分内容阅读
目的:探讨女性尿道腺癌的诊治特点、临床及病理特点。方法:报告我院收治的1例女性尿道腺癌患者,应用免疫组化方法对标本进行分析并对相关文献进行复习。结果:患者行经尿道肿物切除术,术后病理回示:弥漫浸润性中分化尿道腺癌,免疫组化:CK20+、CK7+、PSA-、CEA+、CD10+。术后建议患者行根治性切除手术+全身化疗,患者改中药治疗,目前严密随访中。结论:尿道腺癌是一种罕见尿道肿瘤,目前治疗方法多参照尿道肿瘤治疗,根治性切除术,术后辅以放化疗;局部早期可行局部肿物切除术,疗效也较满意。
Objective: To investigate the diagnosis and treatment of female urethral adenocarcinoma, clinical and pathological features. Methods: One case of female urethral adenocarcinoma admitted to our hospital was reported. The specimens were analyzed by immunohistochemical method and the related literatures were reviewed. Results: The patients underwent transurethral resection of the urethra. Postoperative pathology showed diffuse infiltrative moderately differentiated urethral adenocarcinoma with immunohistochemistry: CK20 +, CK7 +, PSA-, CEA + and CD10 +. Postoperative patients underwent radical resection surgery + systemic chemotherapy, the patient changed traditional Chinese medicine treatment, the current close follow-up. Conclusions: Urethral adenocarcinoma is a rare urethral tumor. At present, the treatment methods refer to urethral tumor treatment, radical resection and postoperative adjuvant radiotherapy and chemotherapy. Local early feasible local tumor resection has satisfactory curative effect.